T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 28.1 CNY -0.64% Market Closed
Market Cap: 2.3B CNY
Have any thoughts about
Tongling Jieya Biologic Technology Co Ltd?
Write Note

Tongling Jieya Biologic Technology Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tongling Jieya Biologic Technology Co Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
T
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Accounts Receivables
ÂĄ170.9m
CAGR 3-Years
3%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Accounts Receivables
ÂĄ2.6B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
4%
Proya Cosmetics Co Ltd
SSE:603605
Accounts Receivables
ÂĄ383.3m
CAGR 3-Years
24%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Accounts Receivables
ÂĄ561.8m
CAGR 3-Years
44%
CAGR 5-Years
40%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Accounts Receivables
ÂĄ249.1m
CAGR 3-Years
15%
CAGR 5-Years
2%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Accounts Receivables
ÂĄ102m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tongling Jieya Biologic Technology Co Ltd
Glance View

Market Cap
2.3B CNY
Industry
Consumer products

Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipes. The company is headquartered in Tongling, Anhui and currently employs 798 full-time employees. The company went IPO on 2021-12-03. The firm's main businesses are the research and development, production and sales of sanitary products. The firm's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The firm is also engaged in the production of facial masks.

Intrinsic Value
22.97 CNY
Overvaluation 18%
Intrinsic Value
Price
T

See Also

What is Tongling Jieya Biologic Technology Co Ltd's Accounts Receivables?
Accounts Receivables
170.9m CNY

Based on the financial report for Dec 31, 2023, Tongling Jieya Biologic Technology Co Ltd's Accounts Receivables amounts to 170.9m CNY.

What is Tongling Jieya Biologic Technology Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
14%

Over the last year, the Accounts Receivables growth was 23%. The average annual Accounts Receivables growth rates for Tongling Jieya Biologic Technology Co Ltd have been 3% over the past three years , 14% over the past five years .

Back to Top